View in Other Languages ข่าวการตลาดออสเตรเลียประจำวันที่ 10 กุมภาพันธ์ 2011: Calzada (ASX:CZD)แถลงผลสำเร็จก้าวหน้าในการวิจัย Human Stem Cell Study For Bone Growth Laporan Pasar Australia 10 Februari 2011: Calzada (ASX:CZD) Mengumumkan Haril Positif dalam Penelitian Stem Cell Manusia untuk Pertumbuhan Tulang 2011年2月10日澳洲股市:Calzada (ASX:CZD)宣布人类骨骼生长干细胞研究取得积极结果 تقرير السوق الاسترالية 10 شباط/فبراير، 2011: أعلنت شركة Calzada ASX:CZD نتائج إيجابية لدراسة على الخلايا الجذعية البشرية لتنمية العظام. Reporte del Mercado Australiano del 10 de febrero de 2011: Calzada (ASX:CZD) Anuncia Resultados Positivos En Células Madres Humanas Para Crecimiento de Hueso Australian Market Report of February 10, 2011: Calzada (ASX:CZD) Announce Positive Results In Human Stem Cell Study For Bone Growth Australischer Marktbericht, 10. Februar 2011: Calzada (ASX:CZD) verlautbart positive Ergebnisse aus Stammzellen-Studie für Knochenwachstum オーストラリア市場レポート 2011年2月10日: Calzada (ASX:CZD) が骨の成長に関するヒト幹細胞研究での前向きな結果を発表 2011년 2월10일 호주 시장보고서: Calzada (ASX:CZD), 골 성장 관련 인간 줄기세포 연구의 긍정적 성과보고 Relatório do Mercado Australiano de 10 de Fevereiro de 2011: Calzada (ASX:CZD) Anuncia Resultados Positivos em Estudo das Células-Tronco Humanas para o Crescimento Ósseo 2011年2月10日澳洲股市:Calzada (ASX:CZD)宣佈人類骨骼生長干細胞研究取得積極結果 
Australian Market Report of February 10, 2011: Calzada (ASX:CZD) Announce Positive Results In Human Stem Cell Study For Bone Growth
Australian Market Report of February 10, 2011: Calzada (ASX:CZD) Announce Positive Results In Human Stem Cell Study For Bone Growth

Sydney, Feb 10, 2011 AEST (ABN Newswire) - Calzada Limited (googlechartASX:CZD) said today that its wholly owned subsidiary Metabolic Pharmaceuticals Pty Ltd had initiated an in vitro study into the effect of AOD9604 on human osteoblasts. AOD9604 performed positively in the study, demonstrating its ability to promote bone growth and to treat diseases such as osteoporosis. Calzada is seeking partnership with pharmaceutical and medical device companies to further develop AOD9604, either as a regulated drug through the traditional pharmaceutical development path or as a cosmetic or nutraceutical with a faster path to market.

PharmAust Limited (googlechartASX:PAA) has signed a binding agreement to purchase 80% interest in a European high grade precious and base metal project, "Luke River". Luke River is an advanced exploration project located in northeast Macedonia. Extensive historical exploration reported high grade precious and base metal mineralisation, with grades up to 16.30g/t gold, 91.50g/t silver, 3.7% lead and 4.0% zinc.

Northern Star Resources Limited (googlechartASX:NST) reported solid production and exploration at its Paulsens gold mine in Western Australia. In January, mining at Paulsens produced 5,957oz gold and gold sales reached 4,946oz, generating revenue of A$6.8 million. Paulsens also returned numerous significant gold intersections of up to 60g/t. The Company plans to announce resource update and new 2011 mine plan in the March Quarter.

Latin Resources Limited (googlechartASX:LRS) has reached an agreement to acquire 14,068 hectares of world class Iron and Heavy Mineral Sands tenements at Guadalupito in Peru. The acquisition adds to the 2,218 hectares already controlled at Guadalupito by the Company's Peruvian subsidiary. Previous drilling at Guadalupito has demonstrated its potential for multi commodity project including Magnetite, Gold, Andalusite, Ilmenite, Zircon, Rare Earths and Tungsten.

Contact

Asia Business News
Tel: +61-2-9247-4344
http://www.abnnewswire.net


ABN Newswire
ABN Newswire This Page Viewed:  (Last 7 Days: 18) (Last 30 Days: 93) (Since Published: 13487) 

View in Other Languages 2232316532161001576914524134871333912864123751099910607 (158919)

googlechart